Zurueck zur Suche

Reporte zur Charge U024507

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 1 TN 1

VAERS 2598872

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024507

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
18.03.2023
Impfdatum
01.03.2023
Beginn
01.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; administered expired PROQUAD; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 01-MAR-2023, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (rHA) subcutaneous injection (lot#: U024507, expiration date: 02-FEB-2023; strength, dose, route of administration, and anatomical location were not reported) which was reconstituted via corresponding sterile diluent (lot#: U006619, expiration date: 09-JUL-2023) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2360811

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U024507

gering
Staat
TN
Alter
16,0
Geschlecht
F
Eingang
07.07.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE information provided.; HCP called to inquire if a PROQUAD dose (first dose) that was administered to 16 year-old female patient on 2/9/2022 is a valid dose.; This spontaneous report was received from a registered nurse, referring to a 16-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 09-FEB-2022, the patient was vaccinated with the first dose of measles, mumps, rubella, and varicella (OKA-MERCK) virus vaccine live (PROQUAD) (valid lot #U024507, expiration date: 02-FEB-2023, therapy type: rHA) (strength, dose, route of administration and anatomical location were not provided) (product administered to patient of inappropriate age) for prophylaxis. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-